癌症丸抗原:新兴的治疗点,利用癌症中的基因组不稳定性
Adviti Naik1, Boucif Lattab1, Hanan Qasem1,2
1Cancer Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha, Qatar.
Molecular therapy. Oncology
|April 10, 2024
概括
癌症丸抗原 (CTA) 是有希望的癌症点,因为它们的瘤特异性表达和免疫性. 剥削CTAs的使用
科学领域:
- 瘤学和免疫学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 癌症治疗的进步包括针对性和基于免疫的治疗,以及手术,化疗和放射治疗.
- 在癌症治疗中优化益处风险平衡仍然具有挑战性,需要高瘤特异性和最小的副作用.
研究的目的:
- 探索癌症丸抗原 (CTA) 作为癌症治疗的治疗策略.
- 研究CTA在维持癌细胞内的基因组完整性方面的作用.
- 讨论利用CTA机制进行向性瘤根除.
主要方法:
- 审查针对CTA的当前临床试验.
- 对基于CTA的治疗方法的临床前数据的分析.
- 讨论CTA在基因组完整性调节中的作用.
主要成果:
- CTAs表现出瘤特异性的表达模式和自然免疫性.
- CTA在瘤细胞存活所必需的生物过程中起着至关重要的作用.
- 在临床前研究中,CTA向策略显示出前景.
结论:
- CTA为癌症干预提供了新的治疗机会.
- 在基因组不稳定中利用CTA功能可以导致向瘤根除.
- 进一步开发基于CTA的战略是有必要的,以应对当前的挑战.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Cancer Vaccines
360
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
360
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


